Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock 70 kDa protein 1A (HSPA1A) is a major member of the Hsp70 family of molecular chaperones, essential for protein quality control in the cell. It stabilizes nascent and misfolded proteins, assists in their refolding, and directs irreparably damaged proteins toward degradation via the ubiquitin-proteasome pathway. Its expression is highly inducible by cellular stresses, such as heat shock and oxidative stress. HSPA1A also inhibits apoptosis by blocking caspase activation and cytochrome c release and is directly involved in DNA repair. Elevated HSPA1A is observed in various cancers, neurodegenerative, cardiovascular, and inflammatory diseases, where it may protect cells, promote survival, and contribute to disease pathogenesis. Due to these functions, HSPA1A is considered a promising, though challenging, drug target in oncology and other fields, but inhibition carries a risk of toxicity due to its central role in cellular proteostasis[1][2][5][7].
Inhibition of ATPase activity; Disruption of chaperone function/protein folding; Promotion of apoptosis by abrogating anti-apoptotic Hsp70 activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock 70 kDa protein 1A (HSPA1A).